Ruxolitinib vs Allogeneic SCT for Patients With Myelofibrosis According to Donor Availability
Ruxolitinib vs Allogeneic SCT for Patients With Myelofibrosis According to Donor Availability
Active, not recruiting · NCT03333187 · Registry updated 2025-03-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ruxolitinib vs Allogeneic SCT for Patients With Myelofibrosis According to Donor Availability | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Active, not recruiting | Phase 2 | 2025-03-30 | NCT03333187 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Clinical Trial Center North (CTC North GmbH & Co. KG) | 2 |
| Novartis | 114 |
| Universitätsklinikum Hamburg-Eppendorf | 136 |
14 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Helios Klinikum Berlin-Buch | Berlin | Germany | 34 |
| Johannes Wesling Klinikum Minden | Minden | Germany | 20 |
| Klinikum Nürnberg | Nuremberg | Germany | 11 |
| Robert-Bosch-Krankenhaus Stuttgart | Stuttgart | Germany | 2 |
| University Medical Center Hamburg-Eppendorf | Hamburg | Germany | 26 |
| Universitätsklinikum Bonn | Bonn | Germany | 4 |
| Universitätsklinikum Düsseldorf | Düsseldorf | Germany | 35 |
| Universitätsklinikum Jena | Jena | Germany | 31 |
| Universitätsklinikum Münster | Münster | Germany | 35 |
| Universitätsklinkum Aachen | Aachen | Germany | 1 |
| Universitätsklinkum Halle | Halle | Germany | 1 |
| Universitätsklinkum Ulm | Ulm | Germany | 1 |
| Universitätsmedizin der Johannes Gutenberg-Universität Mainz | Mainz | Germany | 23 |
| Universitätsmedizin Tübingen | Tübingen | Germany | 1 |